ipilimumab,nivolumab,cabozantinib
exelixis,bms
['rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313', 'biomarker']
discussion for cosmic-313 the os data will be important to balance tox. he highlights the next steps in rcc. the need for drugs new and better biomarkers. we are reaching a plateau with immune checkpoint inhibition and vegf therapy. #esmo2022 
Interested in Urology Cancers, biomarkers and drug development.